Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-cash Items (2018 - 2025)

Historic Non-cash Items for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to $6.6 million.

  • Bicycle Therapeutics' Non-cash Items rose 2999.72% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year increase of 2999.72%. This contributed to the annual value of $9.6 million for FY2024, which is 5639.14% down from last year.
  • Per Bicycle Therapeutics' latest filing, its Non-cash Items stood at $6.6 million for Q3 2025, which was up 2999.72% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Non-cash Items registered a high of $207.0 million during Q4 2021, and its lowest value of $2.2 million during Q2 2021.
  • Moreover, its 5-year median value for Non-cash Items was $18.5 million (2022), whereas its average is $38.3 million.
  • Per our database at Business Quant, Bicycle Therapeutics' Non-cash Items crashed by 9345.68% in 2021 and then soared by 83255.74% in 2023.
  • Quarter analysis of 5 years shows Bicycle Therapeutics' Non-cash Items stood at $207.0 million in 2021, then plummeted by 65.7% to $71.0 million in 2022, then tumbled by 69.13% to $21.9 million in 2023, then tumbled by 56.39% to $9.6 million in 2024, then tumbled by 30.8% to $6.6 million in 2025.
  • Its last three reported values are $6.6 million in Q3 2025, $2.7 million for Q2 2025, and $6.0 million during Q1 2025.